Page last updated: 2024-08-24

plerixafor and ly2510924

plerixafor has been researched along with ly2510924 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Chevassut, T; Ladikou, EE; Pepper, AG; Pepper, CJ1

Reviews

1 review(s) available for plerixafor and ly2510924

ArticleYear
Dissecting the role of the CXCL12/CXCR4 axis in acute myeloid leukaemia.
    British journal of haematology, 2020, Volume: 189, Issue:5

    Topics: Animals; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Benzylamines; Bone Marrow; Cell Adhesion; Cell Hypoxia; Cell Movement; Cell-Derived Microparticles; Chemokine CXCL12; Clinical Trials as Topic; Cyclams; Drug Evaluation, Preclinical; Drug Resistance, Neoplasm; Gene Expression Regulation, Leukemic; Heterocyclic Compounds; Humans; Leukemia, Myeloid, Acute; Mice; Molecular Targeted Therapy; Neoplasm Proteins; Neoplastic Stem Cells; Peptides; Peptides, Cyclic; Pyridines; Receptors, CXCR4; Signal Transduction; Stem Cell Niche; Stromal Cells; Tumor Microenvironment

2020